Pharmtech & Ingredients — 4 important days for pharmaceutical line development

Agreements reached at just a few meetings held within the framework of PharmTech & Ingredients 2018 promise a good utilization of production capacities of our enterprise next year. The planned volumes output of blister foil are the basis for the production expansion. 

Eugeniy Patopakhin, the regional manager, supervisor of pharmaceutical line, has spoken about these and other results of the exhibition.

- Each exhibition is inferior to the previous one in number of new contracts. Being present on the market for more than sixteen years, we know all the interesting players. Instead, the meetings held are very productive. Within 4 days of the exhibition you solve as many issues as you cannot solve on the phone over a year, occasionally.

Pharmaceutical manufacturers prefer to work with our primary packaging for two main reasons. For localized multinationals it is the compliance with GMP requirements in the process of manufacturing pharmaceutical foil in a certified clean room. Visitors of the company’s stand at the exhibition have once again confirmed that they do not see an alternative to our production in Russia.

As for the market players with the Russian founders, by choosing our company such customers are guided by the high printing quality of the most complex, multi-colored designs. Hence, there is another trend of the last exhibition: increasingly greater number of potential customers came to our company by the recommendations of the existing customers.